Full history for every metric is available with a Kvantra account
Field Trip Health Ltd. (FTRP)
Key financial summary
Financials in CAD| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | - | - | - | 0 | 1 | 5 | 4 |
| Operating profit | CAD m | -54 | -57 | |||||
| Net profit | CAD m | - | - | - | -3 | -23 | -56 | -48 |
| EPS reported | CAD | -8.44 | -4.16 | |||||
| Operating cashflow per share | CAD | -6.69 | -6.69 | |||||
| Capex per share | CAD | 0.55 | 0.55 | |||||
| FCF per share | CAD | -7.24 | -7.24 | |||||
| Free cash flow | CAD m | -48 | -46 | |||||
| Net debt | CAD m | -35 | -48 | |||||
| Book value equity | CAD m | 67 | 53 | |||||
| Book value per share | CAD | 10.12 | 4.59 | |||||
| Number of shares | m | 6.61 | 11.63 | |||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.17 | 0.26 | |||||
| P/S LTM | x | 2.28 | 3.50 | |||||
| P/FCF LTM | x | -0.23 | -0.30 | |||||
| EV/EBITDA LTM | x | 0.47 | 0.81 | |||||
| EV/Sales LTM | x | -4.85 | -8.55 | |||||
| Earnings Yield LTM | % | -503.44% | -703.94% | |||||
| FCF Yield | % | -432.14% | -332.19% | |||||
| Quality | ||||||||
| ROE | % | -83.32% | -61.81% | |||||
| ROIC | % | -55.82% | -55.82% | |||||
| Operating margin | % | -1102.8% | -1102.8% | |||||
| Gross margin | % | -88.27% | -88.27% | |||||
| FCF/Sales | % | -985.32% | -985.32% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +405.78% | +121.25% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.65 | - | |||||
| Net Debt/EBITDA | x | 0.69 | 0.69 | |||||
| EBIT/Net interest | x | -48.90 | -48.90 | |||||
| Net debt/market cap | % | -312.85% | -344.54% | |||||
| Net debt/Equity | x | -0.52 | -0.90 | |||||
| Gross debt/equity | x | 0.43 | 0.00 | |||||
Company overview
Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds. Additionally, Field Trip Health Ltd. provides ketamine-assisted therapy to help individuals manage depression, anxiety, addiction, and other related conditions.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Field Trip Health Ltd. (FTRP)
Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds. Additionally, Field Trip Health Ltd. provides ketamine-assisted therapy to help individuals manage depression, anxiety, addiction, and other related conditions.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free